Polyplex Designs for Improving the Stability and Safety of RNA Therapeutics

Adv Drug Deliv Rev. 2023 Jun 24:114972. doi: 10.1016/j.addr.2023.114972. Online ahead of print.ABSTRACTNanoparticle-based delivery systems have contributed to the recent clinical success of RNA therapeutics, including siRNA and mRNA. RNA delivery using polymers has several distinct properties, such as enabling RNA delivery into extra-hepatic organs, modulation of immune responses to RNA, and regulation of intracellular RNA release. However, delivery systems should overcome safety and stability issues to achieve widespread therapeutic applications. Safety concerns include direct damage to cellular components, innate and adaptive immune responses, complement activation, and interaction with surrounding molecules and cells in the blood circulation. The stability of the delivery systems should balance extracellular RNA protection and controlled intracellular RNA release, which requires optimization for each RNA species. Further, polymer designs for improving safety and stability often conflict with each other. This review covers advances in polymer-based approaches to address these issues over several years, focusing on biological understanding and design concepts for delivery systems rather than material chemistry.PMID:37364611 | DOI:10.1016/j.addr.2023.114972
Source: Advanced Drug Delivery Reviews - Category: Drugs & Pharmacology Authors: Source Type: research